Review
Copyright ©2009 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Dec 31, 2009; 1(1): 41-45
Published online Dec 31, 2009. doi: 10.4330/wjc.v1.i1.41
Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin
Shirya Rashid
Shirya Rashid, Department of Medicine, McMaster University, Henderson Research Centre, Hamilton, Ontario, L8V 1C3, Canada
Author contributions: Rashid S solely contributed to this paper.
Supported by Grants from Hamilton Health Sciences, the Canadian Institutes of Health, AstraZeneca and Merck Frosst Schering, A Department of Medicine McMaster University Internal Career Award
Correspondence to: Dr. Shirya Rashid, PhD, Department of Medicine, McMaster University, Henderson Research Centre, Room 206, G-Wing, 711 Concession Street, Hamilton, Ontario, L8V 1C3, Canada. srashid@thrombosis.hhscr.org
Telephone: +1-905-5272299-43780 Fax: +1-905-5752646
Received: December 22, 2009
Revised: December 27, 2009
Accepted: December 28, 2009
Published online: December 31, 2009
Core Tip